Humanin: The Mitochondrial Peptide Linked to a Longer Life?

If MOTS-c is the mitochondrial peptide that caught the longevity world's attention for exercise and metabolism, humanin is its quieter, brain-focused cousin — a peptide tied to neuron protection and, intriguingly, to lifespan itself. Its origin story is genuinely poignant, and the science is real. But, as with every mitochondrial-derived peptide we've covered, there's a wide gap between "fascinating discovery" and "something proven to inject", and that gap is the honest centre of this article.

What is humanin?

Humanin is a very small peptide — and like MOTS-c, it isn't a synthetic invention but a molecule your own mitochondria encode. Mitochondria, the cell's power plants, turn out to send chemical messages to the rest of the body, and humanin is one of them ². Its discovery is part of what makes it compelling: researchers found it while searching for survival factors in a brain region that had been spared in a patient with Alzheimer's disease — essentially asking "what protected these neurons?" Humanin was one answer ³.

So this is, again, not a foreign chemical but a natural part of your own cellular signalling. That's the source of the excitement — and, as always, not the same as proof that supplementing it helps.

What does the research show?

The laboratory and animal story is genuinely interesting; the human-therapy story barely exists yet.

In the lab, humanin is protective. It shields neurons from the amyloid-beta toxicity implicated in Alzheimer's disease and activates cell-survival signalling pathways ³. That neuroprotective signature is what first put it on the map.

In animals, it's linked to healthspan and lifespan. Higher humanin signalling is associated with better stress resistance and, in animal work, with improved healthspan and longer life ¹. Researchers also note that humanin declines with age and is lower in some diseases, which fuels the "restore it to slow ageing" hypothesis ¹.

In humans as a treatment, it's essentially untested. And here's the familiar catch: the human data are largely observational — measuring natural humanin levels and correlating them with age or disease. That's very different from a trial showing that injecting humanin into people is safe or does anything useful. Those trials haven't been done.

That "it declines with age, so top it up" logic is seductive and everywhere in longevity marketing — but a correlation between low levels and disease doesn't prove that adding more reverses anything. It's the same reasoning trap we flag for many hallmarks of ageing interventions.

The approval and sourcing problem

Humanin is not an approved medicine, and what's sold online is an unregulated "research" peptide of unknown purity and dose — the familiar grey-market issues from our peptides guide. For a molecule whose human-therapy evidence is essentially a blank page, that's a lot of unknowns to inject on the strength of a beautiful hypothesis.

What we see at the clinic

Humanin tends to attract the same thoughtful longevity crowd as MOTS-c, and we enjoy the conversation — the biology really is fascinating, and a brain-protective peptide born from studying a resilient Alzheimer's brain is a remarkable story. We're just honest about the state of the evidence: protective in the lab, promising in animals, and untested as a human injection. Following humanin research is genuinely worthwhile; injecting an unregulated version of it today is getting ahead of everything we actually know. The proven path to brain and metabolic ageing still runs through the basics — and, fittingly, exercise raises several of your own mitochondrial peptides for free.

Common questions

Does humanin slow ageing? In animals, higher humanin is linked to better healthspan and lifespan ¹. In humans, the data are observational — there's no trial showing that taking humanin slows human ageing.

Does it protect the brain? It protects neurons in laboratory models of Alzheimer's-related damage ³. Whether injecting it protects human brains hasn't been established.

Is it safe to inject? Unknown — there are no human safety trials, and what's sold is unregulated. "Natural to the body" doesn't make an injected version proven or safe.

How is it related to MOTS-c? Both are mitochondrial-derived peptides — small molecules your mitochondria encode. Humanin leans neuroprotective; MOTS-c leans metabolic. Both share the same "exciting in the lab, untested as a human injectable" status.

Key takeaway

Humanin is a captivating peptide — encoded by your own mitochondria, protective of neurons in the lab, and linked to lifespan in animals, with a discovery story rooted in a resilient Alzheimer's brain. But the human evidence is observational, injecting it as a therapy is untested, and it's sold as an unregulated product. Genuinely exciting research; not a proven treatment. Watch the science with interest, and treat the vial with the scepticism the missing human trials demand.